[ACE inhibitors and early diabetic nephropathy]

Tidsskr Nor Laegeforen. 1995 Oct 10;115(24):3039-41.
[Article in Norwegian]


At present we are able to disclose diabetic nephropathy in the very early stages, i.e. when urinary albumin excretion is only slightly increased (20-200 micrograms/min = microalbuminuria). Good blood glucose control and active antihypertensive treatment may stop or retard the further development towards renal failure. Angiotensin-converting-enzyme (ACE)-inhibitors seem to have a renoprotective effect. In this article we suggest guidelines for the use of ACE-inhibitors in patients with type 1 diabetes and early diabetic nephropathy. Special concerns are included in respect of adolescents, pregnant women and persons with type 2 diabetes.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Albuminuria / drug therapy
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Blood Glucose / analysis
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / metabolism
  • Diabetic Nephropathies / prevention & control
  • Female
  • Humans
  • Male


  • Angiotensin-Converting Enzyme Inhibitors
  • Blood Glucose